90 related articles for article (PubMed ID: 33972685)
1. A seven-gene signature to predict the prognosis of oral squamous cell carcinoma.
Ribeiro IP; Esteves L; Santos A; Barroso L; Marques F; Caramelo F; Melo JB; Carreira IM
Oncogene; 2021 Jun; 40(22):3859-3869. PubMed ID: 33972685
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic implications of genetic alterations in oral cancers.
Pathare SM; Gerstung M; Beerenwinkel N; Schäffer AA; Kannan S; Pai P; Pathak KA; Borges AM; Mahimkar MB
Oncol Lett; 2011 May; 2(3):445-451. PubMed ID: 21546976
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma.
Fan T; Liu Y; Liu H; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J
Cancer Immunol Immunother; 2021 Dec; 70(12):3651-3667. PubMed ID: 33977344
[TBL] [Abstract][Full Text] [Related]
4. Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma.
Lu T; Xu R; Li Q; Zhao JY; Peng B; Zhang H; Guo JD; Zhang SQ; Li HW; Wang J; Zhang LY
Mol Ther Oncolytics; 2021 Jun; 21():134-143. PubMed ID: 33981829
[TBL] [Abstract][Full Text] [Related]
5. A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.
Wu J; Li L; Zhang H; Zhao Y; Zhang H; Wu S; Xu B
Oncogene; 2021 Jul; 40(26):4413-4424. PubMed ID: 34108619
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.
Chang K; Yuan C; Liu X
Front Oncol; 2021; 11():649347. PubMed ID: 33996565
[TBL] [Abstract][Full Text] [Related]
7. Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways.
Ho WJ; Erbe R; Danilova L; Phyo Z; Bigelow E; Stein-O'Brien G; Thomas DL; Charmsaz S; Gross N; Woolman S; Cruz K; Munday RM; Zaidi N; Armstrong TD; Sztein MB; Yarchoan M; Thompson ED; Jaffee EM; Fertig EJ
Genome Biol; 2021 May; 22(1):154. PubMed ID: 33985562
[TBL] [Abstract][Full Text] [Related]
8. Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance.
Lewis JE; Kemp ML
Nat Commun; 2021 May; 12(1):2700. PubMed ID: 33976213
[TBL] [Abstract][Full Text] [Related]
9. Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology.
Sathasivam HP; Kist R; Sloan P; Thomson P; Nugent M; Alexander J; Haider S; Robinson M
Br J Cancer; 2021 Aug; 125(3):413-421. PubMed ID: 33972745
[TBL] [Abstract][Full Text] [Related]
10. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.
Bagaev A; Kotlov N; Nomie K; Svekolkin V; Gafurov A; Isaeva O; Osokin N; Kozlov I; Frenkel F; Gancharova O; Almog N; Tsiper M; Ataullakhanov R; Fowler N
Cancer Cell; 2021 Jun; 39(6):845-865.e7. PubMed ID: 34019806
[TBL] [Abstract][Full Text] [Related]
11. m
Xu F; Huang X; Li Y; Chen Y; Lin L
Mol Ther Nucleic Acids; 2021 Jun; 24():780-791. PubMed ID: 33996259
[TBL] [Abstract][Full Text] [Related]
12. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.
Mao C; Liu X; Zhang Y; Lei G; Yan Y; Lee H; Koppula P; Wu S; Zhuang L; Fang B; Poyurovsky MV; Olszewski K; Gan B
Nature; 2021 May; 593(7860):586-590. PubMed ID: 33981038
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer.
Yin X; Kong L; Liu P
Clin Epigenetics; 2021 May; 13(1):109. PubMed ID: 33980289
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of ferroptosis-related genes in patients with lung adenocarcinoma.
Zhu G; Huang H; Xu S; Shi R; Gao Z; Lei X; Zhu S; Zhou N; Zu L; Mello RA; Chen J; Xu S
Thorac Cancer; 2021 Jun; 12(12):1890-1899. PubMed ID: 33979897
[TBL] [Abstract][Full Text] [Related]
15. The prediction of survival in Gastric Cancer based on a Robust 13-Gene Signature.
Wang G; Zhan T; Li F; Shen J; Gao X; Xu L; Li Y; Zhang J
J Cancer; 2021; 12(11):3344-3353. PubMed ID: 33976744
[TBL] [Abstract][Full Text] [Related]
16. ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
Lou W; Wang W; Chen J; Wang S; Huang Y
Mol Ther Nucleic Acids; 2021 Jun; 24():845-855. PubMed ID: 34026328
[TBL] [Abstract][Full Text] [Related]
17. An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma.
Feng Z; Li K; Lou J; Wu Y; Peng C
Front Cell Dev Biol; 2021; 9():665161. PubMed ID: 33996821
[TBL] [Abstract][Full Text] [Related]
18. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
[No Abstract] [Full Text] [Related]
19. Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma.
Duan J; Lei Y; Lv G; Liu Y; Zhao W; Yang Q; Su X; Song Z; Lu L; Shi Y
PeerJ; 2021; 9():e11074. PubMed ID: 33976960
[TBL] [Abstract][Full Text] [Related]
20. Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC).
Zhong W; Zhang F; Huang C; Lin Y; Huang J
J Cancer; 2021; 12(11):3265-3276. PubMed ID: 33976736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
